Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《基因组蛋白质组与生物信息学报(英文版)》 2004-03
Add to Favorite Get Latest Update

Application of Proteomics in the Study of Tumor Metastasis

Zhen Cai1, Jen-Fu Chiu2 , and Qing-Yu He2 * ,3 ,4 1Department of Surgery, Open Laboratory of Chemical Biology of the Institute of Molecular Technology for 2 Drug Discovery and Synthesis, Institute of Molecular Biology, Department of Chemistry, The University of 3 4 Hong Kong, Hong Kong, China.  
Tumor metastasis is the dominant cause of death in cancer patients. However, the molecular and cellular mechanisms underlying tumor metastasis are still elusive. The identi?cation of protein molecules with their expressions correlated to the metastatic process would help to understand the metastatic mechanisms and thus facilitate the development of strategies for the therapeutic interventions and clini- cal management of cancer. Proteomics is a systematic research approach aiming to provide the global characterization of protein expression and function under given conditions. Proteomic technology has been widely used in biomarker discovery and pathogenetic studies including tumor metastasis. This article provides a brief review of the application of proteomics in identifying molecular factors in tumor metastasis process. The combination of proteomics with other experimental ap- proaches in biochemistry, cell biology, molecular genetics and chemistry, together with the development of new technologies and improvements in existing method- ologies will continue to extend its application in studying cancer metastasis.
【Fund】: This work was partially supported by Hong Kong Re-search Grants Council Grants HKU 7227/02M (toQ.Y.H.) HKU 7218/02M and HKU 7395/03M (toJ.F.C.) the Department of Chemistry and the Areasof Excellence scheme of Hong Kong University GrantsCommittee.
【CateGory Index】: R730.2
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
【Co-references】
Chinese Journal Full-text Database 7 Hits
1 SUN Wei & HE Fuchu Laboratory of Systems Biology, Beijing Institute of Radiation Medicine, Beijing 100850, China Correspondence should be addressed to He Fuchu;Applications of proteomics in hepatic diseases research[J];中国科学(C辑:生命科学)(英文版);2004-02
2 FENG Ju-Tao1), LIU Yin-Kun1), MOHAMAD RADWAN ALMOFTI 2), DAI Zhi1), SONG Hai-Yan1), LU Hao-Jie2), TANG Zhao-You1)**(1) Liver Cancer Institute & Zhong Shan Hospital, Fudan University, Shanghai 200032, China; 2) Proteomics Research Center, Fudan University, Shanghai 200032, China);Screening Serum Biomarkers of Hepatocellular Carcinoma by Two-dimensional Electrophoresis and Mass Spectrometry[J];Progress In Biochemistry and Biophysics;2005-07
3 LIU Chi-bo LIANG Yong PAN Chun-qin (Taizhou Municipal Hospital,Taizhou 318000,Zhejiang,P.R.China);Application of SELDI-TOF-MS technique in diagnosis of hepatocellular carcinoma[J];China Tropical Medicine;2007-01
4 SONG Hai-yan, LIU Yin-kun, CUI Jie-feng, ZHANG Li-jun, DAI Zhi, FENG Ju-tao, FENG Jiu-xian, SHEN Hua-li, YANG Peng-yuan. Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China;Proteomic analysis on metastasis-associated proteins of hepatocellular carcinoma tissues[J];Chinese Journal of Hepatology;2005-05
5 ZHENG Yan-hua~*, ZOU De-wei, FENG Kai, CUI Yan, ZHANG Ming, LI Ning, XU Yang, ZHANG Jian-zhong,~*Department of Pathology and Laboratory Medicine, Beijing 306 Hospital, Beijing 100101, China;Screening of serum biomarkers in hepatocellular carcinoma by SELDI technique:a preliminary study[J];Chinese Journal of Laboratory Medicine;2005-06
6 ZHANG Siwei, LI Liandi, LU Fengzhu, et al. National Office of Cancer Prevention and Treatment, Beijing 100021;Mortality of primary liver cancer in China from 1990 through 1992[J];CHINESE JOURNAL OF ONCOLOGY;1999-04
7 Xiao-Dong Zhu Wei-Jiang Liang Po Tien Department of Molecular Virology,Institute of Microbiology,Chinese Academy of Sciences,Beijing 100080,ChinaWei-Hua Zhang Yang Xu Ciphergen Biosystems,Inc.,Beijing,ChinaCheng-Lin Li Department of Pathology,Beijing You'an Hospital,Beijing 100054,China;New serum biomarkers for detection of HBV-induced liver cirrhosis using SELDI protein chip technology[J];世界胃肠病学杂志(英文版);2004-16
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved